We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Robotic Surgery May Not Improve Outcomes

By HospiMedica staff writers
Posted on 20 Sep 2005
While minimally invasive robotic surgery can result in less blood loss, shorter hospital stays, and fewer complications, there is no evidence that it improves cure rates.

In addition, because the procedure is in high demand and requires special training, it can be unprofitable for hospitals, according to a new review by ECRI (Plymouth Meeting, PA, USA), a nonprofit health services research agency. More...
ECRI reviewed 625 cases in two studies that compared traditional open surgery, laparoscopic surgery, and robotic surgery for the removal of a cancerous prostate.

The cancer cure rate was found to be nearly identical for all three procedures. Hospital stay was significantly shorter, however, with robotic-assisted prostatectomy compared to open surgery: 25.9 hours vs 52.8 hours in one study. Another study showed a significant difference in catheterization time: seven days for robotic-assisted patients, 7.9 days for laparoscopy patients, and 15.8 days for open surgery. Open surgery had a significantly higher overall complications rate of 15%, vs 10% for laparoscopy and 5% for robotic-assisted surgery. There was no evidence to indicate that any surgical method was better than another with regard to side effects such as urinary incontinence and sexual impotency.

Open surgery was clearly the least expensive procedure, at U.S.$487 less per case than laparoscopy and $1,726 less than robotic surgery. "Hospitals have to consider whether they can use the system for more than one type of procedure to make it worth the capital equipment investment,” noted Diane Robertson, director of health technology assessment services for ECRI. "If you have to choose between someone who hasn't performed many robotic surgeries and a person who has performed many open procedures--take the open procedure,” she advised.




Related Links:
ECRI

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.